Coca-Cola Europacific Partners (CCEP) Stock Price & How to Invest

Last updated November 2026

Short answer

Coca-Cola Europacific Partners (CCEP) is the world's largest Coca-Cola bottler by revenue, a UK-incorporated group whose primary listing is on the Nasdaq Global Select Market at roughly ~$49.3bn of market value on ~EUR 21.4bn of trailing revenue as of 16 October 2026, after a ~27% share-price gain so far in 2026. Owning it is a bet on the manufacturing, selling and distribution end of the Coca-Cola system across Western Europe, Australia, Indonesia and the Philippines, which is a different business from the brand-owning Coca-Cola Company (KO).

CCEP stock price

As of 2026-11-16, Coca-Cola Europacific Partners (CCEP) last closed at $119.19, up 32.4% over the past year. Over the past 52 weeks it has traded between $85.43 and $119.19.

CCEP last close
$119.19
1 day
+0.52%
1 month
+6.04%
1 year
+32.43%
52-week range
$85.43 to $119.19
Last close
2026-11-16

Prices are daily closing prices from Yahoo Finance and may be delayed. For the live quote, check your broker or Coca-Cola Europacific Partners's investor relations page. Walnut is informational, not investment advice.

CCEP key stats

At $119.19 on November 16, 2026, Coca-Cola Europacific Partners (CCEP) has a market cap of $52.3B, a P/E of 23.0 on trailing earnings (21.5 on forward earnings) and a dividend yield of 2.02%.

Market cap
$52.3B
P/E (trailing)
23.0
P/E (forward)
21.5
EPS (trailing 12 months)
$5.18
Price to book
5.7
Dividend yield
2.02%
Beta
0.46

Market cap, P/E and yield are measured at the $119.19 price on November 16, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.

What's new with Coca-Cola Europacific Partners (CCEP)?

The last two weeks for Coca-Cola Europacific Partners, as of November 17, 2026: the price move, the next earnings date, what the company filed with the SEC, and what analysts changed.

  • CCEP closed at $119.19 on November 16, 2026, up 1.4% over the past five trading days (from $117.49).
  • On November 16, 2026, Coca-Cola Europacific Partners filed a current report (6-K) with the SEC. Read the 6-K on sec.gov
  • On November 5, 2026, Barclays raised its target to $124.00 from $112.00 (Overweight).
  • On November 4, 2026, UBS raised its target to $115.00 from $107.00 (Neutral).
  • On November 4, 2026, Wells Fargo raised its target to $120.00 from $115.00 (Overweight).

Prices are daily closes from Yahoo Finance. Filings are read from SEC EDGAR every six hours. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.

What does Coca-Cola Europacific Partners (CCEP) do?

Coca-Cola Europacific Partners makes, packages, sells and delivers non-alcoholic ready-to-drink beverages under licence from The Coca-Cola Company and a handful of partner brand owners. Its portfolio spans Coca-Cola, Coca-Cola Zero Sugar, Fanta, Sprite, Schweppes, Monster Energy, Costa Coffee ready-to-drink, Powerade, Capri-Sun, Vitaminwater, Smartwater and, in Australia and the Pacific, the former Amatil brands. The territory list runs across Western Europe (Great Britain, Germany, Spain, France, Belgium, the Netherlands, Portugal, Norway, Sweden, Iceland and smaller markets) plus an Asia Pacific segment built from the 2021 acquisition of Coca-Cola Amatil, which brought Australia, New Zealand, Indonesia, Papua New Guinea and Fiji, and the 2024 purchase of a 60% stake in Coca-Cola Beverages Philippines alongside Aboitiz Equity Ventures. Around ~37,000 employees run the plants, warehouses and route-to-market fleets that reach several hundred million consumers. Ownership is concentrated: Olive Partners, tied to the Daurella family, holds roughly ~36%, and The Coca-Cola Company itself holds roughly ~17%.

The investment picture is a franchised, capital-intensive staples business with better arithmetic than most bottlers get credit for. Trailing revenue of ~EUR 21.4bn converts at roughly ~$24.4bn, operating margin sits near ~13.5%, return on equity near ~23.5%, and Yahoo Finance puts trailing free cash flow at about ~1.6bn against operating cash flow of ~3.0bn. First-half 2026 revenue of ~EUR 10.7bn grew ~4.4% as reported and ~6.1% currency-neutral, with operating profit of ~EUR 1.48bn up ~8.1% currency-neutral, and management reaffirmed full-year guidance of ~3% to 4% revenue growth, roughly ~7% operating profit growth and comparable free cash flow of at least ~EUR 1.7bn. Capital returns are explicit: an interim dividend of ~EUR 0.82 per share, a payout policy around ~50% of comparable earnings, and a ~EUR 1bn buyback that was about ~EUR 593m complete by the end of July 2026. Against that, the stock trades near ~21.7x trailing and ~20.4x forward earnings with ~12.2bn of gross debt, a persistent valuation gap to KO that reflects exactly what a bottler is: the party carrying the trucks, the plants and the packaging regulation.

Since the half-year results the shares have kept climbing. As of the 16 October 2026 close of ~$112.29 they were up about ~27% year to date and ~26% over one year, close to the 52-week high of ~$113.67 and above the analysts' mean target of ~$109.68 (12 analysts, consensus rating buy). Recent commentary is mixed rather than one-sided: in early October UBS said CCEP was likely to post a Q3 organic sales beat, while Jefferies argued European soft drinks growth is slowing as volumes normalise. Consensus looks for Q3 revenue of about ~5.67bn, and full-year 2026 revenue of ~21.6bn rising to ~22.5bn in 2027.

What's driving Coca-Cola Europacific Partners (CCEP)?

1. Asia Pacific scale, with the Philippines as the swing factor

Australia, New Zealand, Indonesia, Papua New Guinea, Fiji and now the Philippines give CCEP a growth engine that a purely European bottler would lack. Coca-Cola Beverages Philippines came in at a $1.8bn enterprise valuation in a 60:40 structure with Aboitiz Equity Ventures, and the value case rests on lifting a large, underpenetrated market toward CCEP's own operating standards. Execution here is where the difference between a mid-single-digit and a high-single-digit grower gets decided.

2. Revenue growth management rather than volume heroics

Most of CCEP's top-line progress comes from price, pack architecture and mix rather than raw litres, which is the standard playbook for a mature European staples business. Small immediate-consumption packs, single-serve chilled placements and premium formats carry far better revenue per litre than multipack take-home. First-half 2026 delivered ~6.1% currency-neutral revenue growth against far more modest volume, which is that mechanism working. Jefferies' October 2026 view that European soft drinks volumes are normalising puts more weight on this pricing and mix lever for the rest of the year, while UBS expects a Q3 organic sales beat.

3. Portfolio mix shifting toward zero sugar, energy and coffee

Coca-Cola Zero Sugar has been the fastest-growing part of the core cola franchise, and CCEP also distributes Monster Energy across its territories plus Costa Coffee ready-to-drink. Energy and zero-sugar formats carry higher margins and sidestep the sugar-tax exposure that hits full-sugar sparkling drinks. Mix shift of this kind compounds quietly and shows up in gross margin rather than in headline volume.

4. Cash conversion funding a dividend and a running buyback

Guidance calls for at least ~EUR 1.7bn of comparable free cash flow in 2026, against a stated payout target near ~50% of comparable earnings and a ~EUR 1bn repurchase programme roughly ~EUR 593m complete by 31 July 2026. Yahoo Finance shows trailing free cash flow of about ~1.6bn on ~3.0bn of operating cash flow, which is a reminder that bottling is capital-hungry, so the durability of that cash conversion is the number that matters most to a long-term holder. Deleveraging after the Amatil and Philippines deals competes directly with buybacks for the same euros.

What are the risks to Coca-Cola Europacific Partners (CCEP)?

Currency is the first thing a US shareholder should understand: CCEP reports in euros while the Nasdaq line quotes in dollars, so a weaker euro compresses reported dollar returns even when the underlying business is fine, and the group also carries Australian dollar, sterling, rupiah and peso translation exposure. Leverage is real, with roughly ~12.2bn of gross debt against ~2.0bn of cash and a debt-to-equity ratio near ~1.39, a legacy of financing the Amatil and Philippines acquisitions. Regulation is a standing headwind rather than an event: sugar levies across the UK, Ireland, Spain, Portugal and elsewhere, extended producer responsibility fees on packaging, deposit return schemes and the EU Packaging and Packaging Waste Regulation all raise the cost of putting a drink on a shelf. The whole business also depends on bottling and distribution agreements with The Coca-Cola Company, which owns roughly ~17% of CCEP and sets concentrate pricing, so the economics are negotiated rather than sovereign. Product-quality events can be expensive and public, as in January 2025 when CCEP recalled Coca-Cola and related products produced at its Ghent plant across Belgium, the Netherlands, Luxembourg, France, Germany and Great Britain after elevated chlorate levels were detected. Valuation is now a risk in its own right: after a ~27% rise in 2026 the shares trade above the ~$109.68 mean analyst target, so a softer Q3 or a volume slowdown of the kind Jefferies flagged in October could weigh on the multiple. As of August 2026 no active US securities-fraud class action against CCEP was identified, and the company filed its FY2025 Form 20-F in March 2026 with continuing routine 6-K filings, with no Form 25 or delisting process in evidence. Walnut is not an investment adviser; this page describes the business and is not a recommendation.

What is the Coca-Cola Europacific Partners (CCEP) forecast?

12 analysts publish price targets on CCEP, averaging $114.68 as of November 2026, or -3.8% against the $119.19 share price on November 16, 2026. The published targets run from $91.52 to $128.65, a moderate spread, and the ratings split 8 buy, 3 hold, 2 sell. Over the last six months there have been 8 raises and 3 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full CCEP forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

Is CCEP a buy or a sell?

We give no verdict on Coca-Cola Europacific Partners. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Asia Pacific scale, with the Philippines as the swing factor. Australia, New Zealand, Indonesia, Papua New Guinea, Fiji and now the Philippines give CCEP a growth engine that a purely European bottler would lack. The most optimistic published target, $128.65, assumes this works close to its best case.

The case against. Currency is the first thing a US shareholder should understand: CCEP reports in euros while the Nasdaq line quotes in dollars, so a weaker euro compresses reported dollar returns even when the underlying business is fine, and the group also carries Australian dollar, sterling, rupiah and peso translation exposure. The most pessimistic target, $91.52, is roughly what CCEP is worth if this bites instead.

Read the full bull and bear case on CCEP, including what would have to change to break either one. Walnut is not an investment adviser.

Has Coca-Cola Europacific Partners (CCEP) split its stock?

No. Coca-Cola Europacific Partners (CCEP) has not split its stock in the last 10 years. The statement covers only the window we check, so an older split in the company’s history is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.

How is Coca-Cola Europacific Partners (CCEP) valued?

Market cap, P/E and dividend yield at today's price are in the CCEP key stats above. The business figures below come from Coca-Cola Europacific Partners's reported results as of October 2026 and change when it next reports.

  • Revenue (TTM): ~EUR 21.4bn (latest qtr ~4.4% YoY)
  • Operating / net margin (TTM): ~13.4% / ~9.4%
  • Free cash flow / operating cash flow (TTM): ~1.6bn / ~3.0bn

As of October 2026: Reported figures are in euros while the Nasdaq line quotes in dollars, so headline conversions move with the exchange rate rather than with trading. After a ~27% year-to-date rise to ~$112.29 on 16 October 2026, CCEP trades at about ~21.7x trailing and ~20.4x forward earnings, slightly above the ~$109.68 mean analyst target, though still at a discount to The Coca-Cola Company. A payout ratio under half of earnings and a ~2.2% yield keep the defensive character, with the Q3 trading update the next datapoint.

Who competes with Coca-Cola Europacific Partners (CCEP)?

Other Coca-Cola system bottlers

Coca-Cola Consolidated (COKE) in the US, Coca-Cola FEMSA (KOF) in Latin America, Coca-Cola HBC in Central and Eastern Europe and Nigeria, Arca Continental and Coca-Cola Bottlers Japan run the same franchised model in different territories. They do not compete with CCEP for customers, since territories are exclusive, but they are the correct comparison set for margin, leverage and valuation, and the spread between them is mostly about market mix and currency rather than operating skill.

Rival beverage systems and brand owners

PepsiCo, Keurig Dr Pepper, Suntory, Red Bull, Danone waters and Nestlé compete for the same chiller space, the same promotional slots and the same grocery listings across Europe and Asia Pacific. Britvic, now inside Carlsberg, is a direct rival in Great Britain and Ireland. Private-label and discounter own-brand colas take share on price in Germany, Spain and the UK during periods of consumer trade-down.

Defensive staples competing for the same capital

For an investor deciding where a defensive allocation goes, CCEP sits next to The Coca-Cola Company itself, Nestlé, Unilever, Diageo and Anheuser-Busch InBev. Those names offer comparable low-beta cash generation with different mixes of brand ownership, emerging-market exposure and regulatory pressure. CCEP's distinguishing feature within that group is a franchised operating model with thinner margins but a tighter, more predictable link between volume, price and cash.

What stocks are similar to Coca-Cola Europacific Partners (CCEP)?

Other names that sit close to CCEP: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. They are useful if you want to spread one thesis across several tickers.

How to invest in Coca-Cola Europacific Partners (CCEP)

There are three common ways to get CCEP exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so CCEP sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where CCEP fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

The bottom line on Coca-Cola Europacific Partners (CCEP)

CCEP is a low-beta, cash-generative bottler with a franchise moat and real regional growth, priced at a modest discount to the brand owner it depends on (about ~21.7x trailing earnings after a ~27% year-to-date rally to near ~$112), and its results reach a US shareholder through a euro reporting currency.

More on Coca-Cola Europacific Partners (CCEP)

Whether CCEP is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is CCEP a buy or a sell?, and where the stock could go from here in the CCEP stock forecast.

For income investors, whether CCEP pays a dividend and how the payout looks is covered in does CCEP pay a dividend? And to weigh CCEP against a peer, read the full side-by-side comparisons: CCEP vs KO and CCEP vs COKE.

Wondering how CCEP fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Coca-Cola Europacific Partners

Ask Walnut's AI anything about CCEP and see how it fits what you own.

FAQ

What does Coca-Cola Europacific Partners actually do?

+

It manufactures, packages, sells and delivers non-alcoholic drinks under licence from brand owners, principally The Coca-Cola Company. Concentrate arrives from the brand owner; CCEP adds water, sweetener and carbonation, fills bottles and cans, and runs the warehouses, trucks and sales force that get them into supermarkets, restaurants and vending machines across ~31 markets.

Is CCEP the same thing as The Coca-Cola Company (KO)?

+

No. KO owns the trademarks, sets the marketing and sells concentrate; CCEP is a separately listed bottler that buys that concentrate and does the physical work. KO holds roughly ~17% of CCEP, but they are distinct companies with different margins, different capital intensity and different valuations, with CCEP typically trading at a lower multiple.

Where is CCEP listed, and can a US investor hold it directly?

+

Its primary listing is on the Nasdaq Global Select Market under CCEP, with additional listings on Euronext Amsterdam, the London Stock Exchange and the Spanish exchanges. Because the Nasdaq line is an ordinary share listing rather than a thin ADR, it trades in US dollars through any standard US brokerage account during regular US market hours.

What currency does CCEP report in, and why does that matter?

+

Financial statements are prepared in euros, so revenue of ~EUR 21.4bn on a trailing basis has to be translated into dollars before it can be compared with the dollar share price. A US holder therefore takes euro exposure on top of business performance, and management routinely reports currency-neutral growth alongside reported growth precisely because the two can diverge by several percentage points in a year.

Does CCEP pay a dividend?

+

Yes, on a semi-annual pattern, with an interim dividend of ~EUR 0.82 per share declared in 2026 and a stated policy of paying out around ~50% of comparable earnings. The trailing yield sits near ~2.2% as of October 2026 (about ~$2.41 a share annualised) at a payout ratio around ~47%; the yield has slipped because the share price rose about ~27% this year. Dividends are declared in euros, so the dollar amount received varies with the exchange rate on the payment date.

Which markets matter most to CCEP's results?

+

Western Europe remains the profit centre, with Great Britain, Germany, Spain and France the largest contributors. The Asia Pacific segment covering Australia, New Zealand, Indonesia, Papua New Guinea and Fiji came from the 2021 Amatil acquisition, and the Philippines was added in 2024 through a 60:40 venture with Aboitiz Equity Ventures at a $1.8bn enterprise valuation. Growth skews toward the Asia Pacific side while cash generation skews European.

How much debt does CCEP carry?

+

Roughly ~12.2bn of gross debt against about ~2.0bn of cash as of the latest half-year balance sheet, with a debt-to-equity ratio around ~1.39 and a market cap near ~$49.3bn in October 2026. That balance sheet is a direct legacy of the Amatil and Philippines acquisitions, and deleveraging competes with the buyback for the same free cash flow, which is worth watching in any year when operating cash conversion slips.

What are the main things that could change the story?

+

Sustained euro weakness would depress dollar-reported results without touching the underlying business. Slower-than-planned margin improvement in the Philippines would undercut the growth case built into the multiple. Tighter packaging and sugar regulation across Europe raises structural cost, and any renegotiation of the bottling agreements with The Coca-Cola Company would go straight to concentrate economics, which is the single largest input line CCEP does not control. Closer in, the Q3 trading update will show whether the volume normalisation Jefferies described in October is offsetting price and mix, and with the shares near a 52-week high and above the average analyst target, a miss would land on a fuller valuation.

How did Coca-Cola Europacific Partners do in its latest results?

+

First-half 2026 revenue was ~EUR 10.7bn, up ~4.4% reported and ~6.1% currency-neutral, with operating profit of ~EUR 1.48bn up ~8.1% currency-neutral, and management reaffirmed full-year guidance of ~3% to 4% revenue growth and roughly ~7% operating profit growth. The second quarter alone brought revenue of about ~5.72bn. Consensus looks for Q3 revenue of about ~5.67bn, and UBS said in October it expects an organic sales beat.

How has CCEP stock performed in 2026?

+

Strongly for a staples bottler. As of the 16 October 2026 close of ~$112.29, CCEP was up about ~27% year to date, ~26% over one year and ~12.5% over the past month, trading near its 52-week high of ~$113.67 (low ~$84.66). That move has taken the shares slightly above the ~$109.68 mean analyst target.

Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with Coca-Cola Europacific Partners's investor relations page or your broker before making investment decisions.